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Study Design. A comparative in vitro metalloproteinases gene expression profile    
 Objectives.  To obtain a complete expression profile of MMPs, ADAMTSs and TIMPs 
in bovine adult nucleus pulposus cells and to compare this profile with the expression profile 
obtained from bovine adult articular chondrocytes cultured under identical conditions. 
 Summary of Background Data. The cells of the nucleus pulposus (NP) resemble 
articular chondrocytes morphologically but produce a matrix which, though consisting of 
similar components, has very different biomechanical properties. No specific markers for NP 
cells have yet been identified; they can be distinguished from chondrocytes only by 
differences in gene expression.  Here we compare profiles of gene expression of 
metalloproteinases and their inhibitors between NP cells and chondrocytes to improve 
understanding of the differences between these cell types. 
Materials and Methods.  NP cells and articular chondrocytes were harvested respectively 
from bovine caudal discs and the articular cartilage of metacarpal-phalangeal joints of 18-24 
month old steers.  These cells were cultured under identical conditions for 72 hours in 
alginate beads. Expression levels of MMPs, ADAMTSs and inhibitors were detected by 
Real-time RT-PCR. 
Results. Gene profiling demonstrated distinct differences between levels of MMPs, 
ADAMTSs and TIMPs produced by chondrocytes and NP cells. In particular, NP cells 
expressed considerably more MMP-2 and MMP-14 than chondrocytes, and expression of 
ADAMTS-1,-2,-17 and TIMP-1 was also higher. However expression of 
MMP-1,-3,-7,-8,-10,-11,-13,-16,-19,-20,-21,-23,-24,-28,  ADAMTS-4,-5,-6,-14,-18,-19 and 
TIMP-3 was lower in NP cells than in chondrocytes. Chondrocytes but not disc cells 
expressed MMP12 and MMP27; this difference is a potential marker for distinguishing 
between NP cells and chondrocytes.   
Conclusion.  Since culture conditions and animal age were identical, differences in 
metalloproteinase and inhibitor expression between NP cells and chondrocytes were intrinsic 
to cell phenotype and not induced by differences in the in situ extracellular environment. 
 
  
 
 
Key Points. 
• Profiles of metalloproteinase and their inhibitors expressed by bovine nucleus 
pulposus cells were compared with those expressed by bovine articular chondrocytes 
• The animals were of identical ages and the cells were cultured under identical 
conditions;  differences in gene expression were thus intrinsic to cell phenotype 
rather than to environment 
• There were significant differences between disc cells and chondrocytes in gene 
expression profiles 
• Chondrocytes but not disc cells expressed MMP12 and MMP27, potentially providing 
a negative marker for distinguishing nucleus cells from chondrocytes. 
 
Key words:  MMP, ADAMTS, TIMP, nucleus pulposus, phenotypic markers    
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Mini Abstract 
Expression levels of metalloproteinases and their inhibitors in bovine nucleus pulposus cells 
and articular chondrocytes were determined using qRT-PCR.  Under identical culture 
conditions, chondrocytes but not NP cells expressed MMP12 and MMP27, potentially 
providing a means of distinguishing between NP cells and chondrocytes in cell differentiation 
studies. 
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INTRODUCTION 
 
In intervertebral discs the load-bearing properties arise from the composition and organisation 
of the extracellular matrix (ECM) which, as in all cartilaginous tissuses, consists 
predominantly of type II collagen and aggrecan but also contains a large number of minor 
components important for tissue integrity and function1,2. The ECM is constantly synthesized 
by cells of disc or degraded by proteinases produced by disc cells. Normally rates of synthesis 
and breakdown are in balance, but in disc degeneration the balance is shifted towards 
degradation3,4 with consequent loss of matrix components, disturbances of tissue architecture 
and of biomechanical function leading possibly to clinical consequences5-7. The major 
enzymes responsible for this destruction are metalloproteinases, including the family of 
matrix metalloproteinases (MMPs), and the family of proteases with a disintegrin and 
metalloproteinase domain with thrombospondin motifs (ADAMTS). Tissue inhibitors of 
metalloproteinases (TIMPs) are also made by disc cells; these are endogenous inhibitors of 
metalloproteinase activities and thus also play an important role in regulating tissue turnover. 
 
Both metalloproteinase families have a number of members. The MMP family comprises of 
23 members8 which share a common catalytic core with a zinc molecule in the active site. The 
MMPs can degrade all the components of the ECM which exist within the IVD.  They can 
be divided into four main subfamilies: collagenases, stromelysins, gelatinases, and membrane 
MMPs. Regulation of MMP activity in tissues is complex. MMPs are secreted as pro-forms 
(inactive precursors), cleaved to become active, and then can be inhibited by being bound to 
their inhibitors, the TIMPs, in a 1:1 molar ratio9,10. The ADAMTS family contains 19 
members which have highly selective proteolytic activities. Six members 
(ADAMTS-1,-4,-5,-8,-9,-15) of this family show a particular avidity for aggrecan and thus 
have been termed aggrecanases11. In vivo, aggrecanolysis probably involves both MMPs and 
aggrecanase activities12. The TIMPs (TIMP-1,-2,-3,-4) show little inhibitory specificity 
although TIMP-3 reportedly selectively inhibits members of the ADAMTS family13-15.  
 
A number of studies have examined expression and activity of different members of the MMP 
and ADAMTS families of metalloproteinases in both normal and degenerate discs3,4,13,14,16-21 
but metalloproteinase expression and activity has been far more extensively studied in 
articular cartilage22, in many respects a similar tissue.   However, it is not clear to what 
extent information relating to cartilage and articular chondrocytes is applicable disc and disc 
cells even though mature NP cells are commonly characterised as being ‘chondrocyte-like’. 
Like articular chondrocytes NP cells are spherical and in situ exist in isolation, embedded in a 
dense avascular matrix surrounded by a pericellular capsule which differs in composition 
from that of the inter-territorial matrix23. Like chondrocytes disc cells synthesize primarily 
type II collagen and aggrecan but also a complex pattern of other matrix macromolecules. 
However the matrix synthesized by disc NP cells is distinctly different in organisation and 
properties from that of articular cartilage and other differences in cell phenotype have been 
reported23,24.  Although it is thus apparent that this chondrocyte-like characterisation of NP 
cells is an over-simplification, surprisingly little is known about what distinguishes NP cells 
from articular chondrocytes and how this influences the production of metalloproteinases 
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involved in normal tissue homeostasis as well as tissue degradation.     
 
Here we aim to profile all of the known MMP, ADAMTS, and TIMP genes expressed by NP 
cells as degradation of the nucleus appears the controlling step in degradation of the whole 
disc.  We also compare the expression profile with that of articular chondrocytes.  This data   
will aid in the understanding the regulation of matrix turnover and degradation in the IVD.  
In addition it provides useful comparative information between the cellular biology of the 
cartilage and the IVD in regard to expression of agents involved in matrix degradation. 
 
MATERIALS AND METHODS 
Disc nucleus cells and articular chondrocytes cultured in alginate beads 
Bovine caudal discs and metacarpal-phalangeal joints from 18-24 month old cattle were 
obtained from a local abattoir. The nucleus pulposus (NP) from the upper 6 coccygeal discs 
were dissected from bovine tails under sterile conditions. Similarly, articular cartilage was 
dissected from the metacarpal-phalangeal joints. Three tails and 1 joint were used for each 
cell isolation. Three independent cell isolations and cultures were carried out for the work 
described here.  Cells were isolated from the nucleus and cartilage by digestion with 
0.4mg/mL of collagenase type I (C-0130, Sigma-Aldrich Co., Poole, Dorset, UK) for 24 hours 
at 37oC! following the method described by Maldonado and Oegema25. NP cells and 
chondrocytes were resuspended uniformly in 1.2% alginate (Cat. No.71238, Sigma-Aldrich 
Co., Poole, Dorset,UK ) solution at a density of 4 million cells/ml. Alginate beads of 
approximately 15µl each were formed by expressing the cell suspension through a 21G needle 
attached to a 5ml syringe into a 102mM CaCl2 solution26. NP cells and chondrocytes were 
each cultured in alginate beads at an osmolarity of 380mOsm (i.e similar to the osmolarity 
seen in situ27) for 72 hrs in Dulbecco’s modified eagles medium (DMEM) (Cat.No.10106169, 
Invitrogen Co., Paisley, UK) containing 10% foetal bovine serum, followed by 24 hrs culture 
in serum-free DMEM. 
 
RNA extraction from disc nucleus cells and articular chondrocytes 
For extraction of RNA, 25 beads (approximately 1 million cells) from each sample were 
placed in a sterile tube and the remaining medium was aspirated off. Beads were dissolved by 
adding 3 volumes of citrate buffer (55 mM sodium citrate, 50 mM EDTA, 0.15 mM sodium 
chloride, pH 7.428) and shaking gently. The cells were thus freed and were pelleted by 
centrifugation for 5 min at 600g. The cells were washed with phosphate-buffered saline and 
pelleted by centrifugation for 5 min at 600g; supernatant was carefully removed. Total RNA 
was isolated from these cells using a Qiagen RNeasy Mini Kit (74104, QIAGEN, Crawley, 
UK) as per the manufacturer’s instructions. Purified RNA was quantified by 
spectrophotometry29. 
 
Synthesis of complementary DNA. 
Complementary DNA (cDNA) was synthesized from 0.75g of total RNA using Superscript 
II reverse transcriptase (Invitrogen, Paisley, UK) and random hexamers in a total volume of 
 6 
20l, according to the manufacturer’s instructions and essentially as previously described30. 
cDNA was stored at -20°C until used in downstream real-time RT-PCR. 
 
Real-time RT-PCR. 
Oligonucleotide primers were designed using DNAstar (DNAstar Inc.) The primer sequences 
used to amplify a number of MMP, ADAMTS and TIMP bovine genes have been previously 
described30 with primer sequences to other remaining family members listed in Table 1. 
Relative quantitation of genes was performed using the ABI Prism 7900HT sequence 
detection system (Applied Biosystems, Foster City, CA, USA). Metalloproteinase and 
inhibitor expression were determined using SYBR Green (Takara Bio Inc.) using the 
manufacturer’s suggested protocol. PCR reaction mixtures contained 2ng cDNA, 50% 
SYBR-Green PCR mix (Takara) and 100 nM of each primer in a total volume of 25l.  
 
The 18S ribosomal RNA gene was used as an endogenous control to normalize for differences 
in the amount of total RNA present in each sample; 18S rRNA TaqMan primer and probe 
were purchased from Applied Biosystems. TaqMan mastermix reagents (Sigma-Aldrich Co., 
Poole, UK) were used according to the manufacturer’s protocol. The calculation 2-(CT gene – CT 
18S)
 (2-CT) was used as an approximate measure of gene expression to allow comparison of 
levels between genes. 
 
Statistical analysis 
Levels of mRNA for each gene were corrected using the 18S rRNA levels as described above, 
and all statistical tests were performed using these log ratios on the samples from a 
quintuplicate experiment. The significance of differences between the disc nucleus cells and 
articular chondrocytes was determined using Student T test.  Data presented is from a single 
experiment and but is representative of that from three individual experiments. 
 
RESULTS 
The expression of 22 known bovine MMP, 18 ADAMTS genes, and 4 TIMP genes at the 
mRNA level was determined in bovine NP and articular chondrocytes by real-time RT-PCR.   
The cells were from animals of the same age and were cultured under identical conditions in 
alginate beads for 72 hours.  
 
Summary of gene expression levels.  
Mean relative expression levels are shown in Figure 1.  Expression of most MMP genes was 
detected in bovine nucleus cells and articular chondrocytes. Of all the genes quantified, 
MMP-3 was the most highly expressed in both nucleus cells and chondrocytes. In general 
patterns of expression levels were similar between the two cell types; levels of 
MMP-1,-2,-7,-8,-9,-13,-14,-15,-16,-19,-21,-23,-24,-25  were similar in both nucleus cells 
and chondrocytes.  Low expression levels of MMP-10,-11,-17,-20 were found in both 
nucleus cells and chondrocytes.   However expression of MMP-28 was considerably higher 
in chondrocoytes than in nucleus cells whereas, while expression of MMP-12 and MMP27 
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was low in chondrocytes, it could not be detected in nucleus cells (Figure 1). 
All ADAMTS genes were expressed by disc nucleus cells and articular chondrocytes, but 
none was highly expressed.  Medium levels of  
ADAMTS-1,-2,-4,-5,-6-7,-8,-9,-15,-17,-18,-19,-20 were detected in nucleus cells and 
chondrocytes. The expression levels of ADAMTS-10,-13,-14,-16 were low both cell types 
(Figure 1) but ADAMTS-12 expression was noticeably higher in chondrocytes than in disc 
cells. 
 
All TIMPs with the exception of TIMP-4, were expressed by both cell types. The expression 
level of TIMP-1,-2 were medium in both nucleus cells and chondrocytes however TIMP-3 
levels were noticeably lower in nucleus cells than in chondrocytes (Figure 1).   
 
Genes showing significant difference in expression level between NP cells and articular 
chondrocytes are summarised in Table 2 together with their matrix targets.  
 
Gene Expression: Comparison between Bovine Disc Nucleus Pulposus Cells and 
Articular Chondrocytes 
Figure 2 shows details of MMP expression levels in NP cells and chondrocytes. Of the MMPs, 
only MMP-2 and MMP-14 gene expression was higher (1.76 fold and 1.78 fold respectively) 
in nucleus cells than in chondrocytes. MMP-1,-3,-8,-16, and MMP-19 expression was much 
lower (p<0.001) in nucleus cells while MMP-12 and MMP-27 were not detected. Of the 
gelatinases, expression of MMP-2 (gelatinase-1) was 1.76 fold higher (p<0.05) in nucleus 
cells, while MMP-9 expression did not differ significantly from that in chondrocytes. All the 
classical collagenases, MMP-1,-8,-13 were expressed at lower levels (55.6 fold, 2.67 fold and 
2.79 fold respectively) in nucleus cells than in chondrocytes as were the stromelysins, 
MMP-3,-10,-11 (3.34 fold, 2.66 fold and 1.64 fold respectively). Of the membrane-type 
MMPs, MMP-14 (Membrane-type 1 MMP) was 1.78 fold higher in nucleus cells than that in 
chondrocytes, whilst the opposite was true for MMP-16 and MMP-24 (8.68 and 2.49 fold 
respectively). The expression levels of MMP-15,-17,-25 did not differ between the two cell 
types.  Matrilysin, MMP-7, expression was 2.46 fold lower in nucleus cells than that in 
chondrocytes.    
 
Figure 3 shows details of ADAMTS gene expression levels. Of all the ADAMTS genes, only 
ADAMTS-1,-2 and ADAMTS-17 were more strongly expressed (5.61 fold, 3.47 fold and 
1.92 fold respectively) in nucleus cells. ADAMTS-4,-5,-6,-14,-18, and ADAMTS-19 were all 
expressed at lower levels in nucleus cells. Of the known aggrecanases 11, expression of 
ADAMTS-1 was 5.61 fold higher in nucleus cells and ADAMTS-4 and ADAMTS-5 lower 
(5.46 fold and 8.23 fold respectively), whilst ADAMTS-8, ADAMTS-9 and ADAMTS-15 did 
not differ significantly from that in chondrocytes. Of the procollagen propeptidases 
ADAMTS-2 expression was 3.47 fold higher in nucleus cells, while ADAMTS-14 was lower. 
Of the remaining ADAMTS genes, expression of ADAMTS-7,-10,-12,-13,-16, and 
ADAMTS-20 were not significantly different between nucleus cells and chondrocytes. 
(Figure 3. Table 2.) 
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Figure 4 gives details of TIMP expression levels. All TIMP genes expressed were seen in both 
nucleus cells and articular chondrocytes. TIMP-1 expression was 2.94 fold higher in nucleus 
cells whilst TIMP-3 expression was 240.16 fold lower. No significant difference between 
nucleus cells and chondrocytes was observed for expression of TIMP-2. TIMP-4 expression 
was not detected in either cell type.  
 
DISCUSSION 
Differences in expression profiling of metalloproteinases between nucleus cells and 
articular chondrocytes 
Here we report on a study which profiles the expression of genes from the MMP, ADAMTS, 
and TIMP families in cells from the nucleus pulposus of adult bovine intervertebral discs and 
compare the results with findings in bovine articular chondrocytes.  The animals were in the 
identical age range and the cells were cultured under identical conditions for 72 hours.  
Under our culture conditions we found that there are a total of 28 genes with statistically 
significant differences in expression levels between nucleus cells and chondrocytes (Table 2). 
These differences, whether they are intrinsic or arise because of different responses to their 
common culture conditions, add weight to the suggestion that there are phenotypic and 
metabolic differences between these cell types.  Furthermore the results identify proteinases 
that have not previously been implicated in disc metabolism, viz. MMP-11, MMP-16, 
MMP-19, MMP-23, MMP-28, ADAMTS-2, and ADAMTS-14.  As discussed below, all 
these proteinases have the potential to degrade matrix components, are upregulated in 
degradative disorders in other tissues and thus possibly play an important role in the processes 
of disc degeneration.  
 
While the roles of MMP-11, MMP-16, MMP-19, MMP-23 and MMP-28 in the disc are 
unexplored, there is now increasing evidence that all of these MMPs are involved in 
degradation of other cartilaginous tissues and that their activity is upregulated in pathological 
conditions.  MMP-11, stromelysin 3 has only a weak activity toward extracellular matrix 
macromolecules31 but is known to be  up-regulated in osteoarthritic (OA) chondrocytes, 
cartilage and synovium 32,33 and is also present a higher levels in painful and ruptured 
tendon34. MMP-16, namely MT3-MMP, is one of the 4 members of MT-MMP family, which 
is known to activate the zymogen of MMP-235. It plays a role in chondrogenesis and cartilage 
development36,37. Its expression is increased in human OA cartilage38 and synovium33. 
MMP-16 is also intensely expressed in rheumatoid (RA) synovium and synovial tissue39,40, 
and is higher in the painful compared to normal tendon34. MMP-19 is a novel member of the 
MMP family which is widely expressed in body tissues, including the synovium of normal 
and RA arthritic patients. Although the physiological substrates of MMP-19 are unknown, in 
vitro it is able to degrade both aggrecan and cartilage oligomeric matrix protein (COMP) 
which are found in cartilage41. MMP-23 expression has been shown to be up-regulated in OA 
cartilage when compared with macroscopically normal tissue from fracture to the neck of 
femur33, however the substrates and the functions of MMP-23 in the cartilage matrix turnover 
are as yet unknown42. MMP-28, a recently identified member of the MMP family is also 
found elevated in cartilage from both OA and RA patients, which suggests a role for the gene 
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in cartilage degradation and/or repair33,38,43. The macrophage elastase MMP-12 is known to be 
expressed by chondrocytes44 and may decrease during OA progression33; excessive MMP-12 
expression can exacerbate articular connective tissue and cartilage degradation45.Virtually no 
studies have concentrated specifically on MMP-27, and scarce general data are available so 
far. However mRNA of MMP-27 was shown to be present in the bone, kidney, heart and 
several other tissues in the rat46.  The high expression levels of MMP-17 in rat bone are to 
some degree in line with findings in human cartilage, where high expression has been 
reported and implicated in osteogenesis38.  We found that the both cells types expressed 
ADAMTS-2 and ADAMTS-14, which are procollagen N-proteinases involved in collagen 
biosynthesis47, with ADAMTS-2 expression significantly higher and ADAMTS-14 
expression much lower in NP than in articular chondrocytes. Both ADAMTS-2 and 
ADAMTS-14 expression is increased in osteoarthritic cartilage33,38. Thus, even though most 
of these proteinases were expressed at lower levels by nucleus cells than chondrocytes in our 
cultures, the role of these MMPs in degenerated and painful discs thus bares investigation.  
 
It should be noted that MMP-12 and MMP-27 genes were not detected in bovine nucleus cells 
and therefore represent possible markers to distinguish bovine NP cells from articular 
chondrocytes, at least in our culture system. However, their use as potential markers under all 
conditions and for human discs does require further investigation.  
 
TIMP-4 expression could not be detected in either bovine nucleus cells or articular 
chondrocytes. This was somewhat surprising because, although there are no reports 
examining the expression of TIMP-4 in IVD, expression of the gene has been detected in 
bovine nasal cartilage30. Expression of the gene has also been detected in human femoral head 
cartilage although reports of differential expression of the gene in OA are somewhat 
conflicting with one group finding an increase48 and another a decrease33,38. 
 
Bovine and human cartilage have similar metalloproteinase expression profiles 
Obtaining healthy human nucleus cells for biological research is difficult. The general 
properties of bovine coccygeal discs, such as cell phenotype, composition, swelling pressure, 
and proteoglycan synthesis are similar to those of human lumbar discs and they thus have 
been suggested as a suitable model for the study of the metabolic and other properties of 
human lumbar discs49,50  We thus carried out this study on bovine discs.   
 
Although we have no direct human disc cell data for comparison there are studies on 
proteinase and TIMP expression for human chondrocytes. Our studies on bovine articular 
chondrocytes found metalloproteinase expression profiles similar to those reported for human 
chondrocytes. When compared to the most comprehensive study of MMP, ADAMTS and 
TIMPS gene expression by human chondrocytes (from femoral head cartilage33), our data on 
bovine articular chondrocyte gene expression is very similar especially in regard to MMP-1, 
MMP-2, MMP-3, MMP-12, MMP-17, MMP-28, ADAMTS-2, ADAMTS-4, ADAMTS-5, 
ADAMTS-14, ADAMTS-15, ADAMTS-16, ADAMTS-17, ADAMTS-20, TIMP-2, TIMP-3 
even though Davidson et al.33 isolated RNA directly from cartilage while here chondrocytes 
were isolated from cartilage by sequential enzymatic digestion and cultured in alginate. This 
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similarity between human and bovine cartilage in terms of expression patterns of 
metalloproteinases and inhibitors might suggest that bovine coccygeal disc cells cultured in 
alginate may likewise show similar expression patterns to those of human disc NP cells.   
 
CONCLUSION 
The role of metalloproteinases in disc physiology and pathology is still very unclear. In 
humans, disc degeneration can be observed histologically in the nucleus pulposus as early as 
in the second decade of life; the earliest signs of disc degeneration appear on magnetic 
resonance imaging in the nucleus pulposus soon after the disappearance of notochordal 
cells51,52. These age-related changes in composition and structure of the intervertebral disc 
occur earlier and to a greater extent than in any other source of cartilage53. The reasons for the 
early degeneration in disc remain unclear.  Metalloproteinases have an essential role during 
growth and in normal tissue homeostasis in the adult; murine gene deletion studies have 
shown that the lack of a given metalloproteinase can exacerbate cartilage destruction and 
subsequent arthritis54. Indeed many of the aggrecan molecules in normal discs are 
proteolytically degraded soon after biosynthesis 55,56 and yet have a long half-life (decades) 
and are osmotically active 57.  It is however evident that genes of the metalloproteinase 
family and their inhibitors also play an essential role in the deregulation of the normal 
homoeostatic mechanism in disc5,14,58 and in the consequent degradative processes.  
Meanwhile, in disc degeneration, although there is an increase in matrix degradation 
associated with deregulation of the 3 metalloproteinase/inhibitor gene families the situation is 
further complicated by a concomitant change in matrix synthesis’ for instance levels of 
collagens type I and III can increase but production of aggrecan decreases14. Further work is 
required to confirm that the gene expression profile reported here is reciprocated at the protein 
and enzymatic level and to determine changes that occur upon initiation of disc degeneration. 
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Table 1: Sequence data for bovine metalloproteinase and inhibitor primers for real-time PCR 
Gene Sequence(5’-3’) Gene Sequence(5’-3’) 
GGAGAAGCCCAGATGTGGAG GGGCCTACCTCCAGCAGAAGC MMP-7 
TGGATGATTTGGGAATAGCGA 
ADAMTS-2 
GCCCAGCCGCACCTCGTCAC 
TGGGCTGTCAGAAGAGTT ATCCACAACAGGCAGTATCTAA MMP-10 
TTATCAGAAGTAGCTACATCAGTT 
ADAMTS-6 
CTTGCAAGTATCCTGTGTAATGAC 
CTTTGACGCAGCCGCCACCATC CAGAGGACAGCCAGAGCCTA MMP-11 
GTTCTTCTCGGAGCCCCACACCAG 
ADAMTS-7 
CAGAAACCTCATTGGTCCTCTC 
CTGCGGCGGCGGAGGAAGC GCCAAGCCACCAGCCACCAT MMP-15 
CCAAACCAGGGCCAGGGAAATAGG 
ADAMTS-10 
CCCAGCCCGCGCACATCCA 
CTGACCAAGTGGAACAAGAGGAAC GGCAGGGACCATCTTTCAATACGA MMP-17 
TGTGGTGGTCGCCCGGGAAGAAGG 
ADAMTS-12 
CCCACGGCCCTTCTTCACG 
TACCGGCCCTACTTCAAGC CTGCGGAGGCGGCGTGATTAC MMP-19 
TTGCCATAGAGAGCCTGGAT 
ADAMTS-13 
GTCTTCTCGCAGGCCTGGGTGTTG 
CCTTCGATGCTGTGACGAT AGCTGATGTCCGGGAACTTGTGA MMP-20 
AGAAAATCCGGTCCCTGAAG 
ADAMTS-14 
AGAGGTCCTGGGAGCGGTGTGG 
TCAGGCCCACTCAGAAGATG TTGCCATTGTCGCCCTGATTCTTC MMP-21 
CAGGGGATTTGGGATGTGAGG 
ADAMTS-16 
GCATATGTCCAGGCCGGTGAGTAA 
CGCTTCTACCCCGTCAAC GACTACTCCGGCTGCTACGA MMP-23 
GTCGAAGCAGTGGTGCAG 
ADAMTS-17 
GCAGGTCGACGAGCACTTA 
GGAGGGCAGGATAACCAGA CCTTGTGATAAAAACAGCTTGGA MMP-24 
GTGGAAAACACGGTCTTTGACT 
ADAMTS-18 
CGGAAAGGCTTGCTGTTATACT 
GAGGGGACGGACCTGTTT TGGTGAATGGATTAAAGGACAA MMP-25 
GGCCTCATGATGGAGTCG 
ADAMTS-19 
CCAAATCTTCCTTGCTACATCG 
GGTGTGGGGTGCCTGACG CCCTGCCATGGTGATTGT MMP-27 
CCCTTTGGAAATCTTGGTGAATA 
ADAMTS-20 
AAGTTCCTGGCATTCTCTGTC 
GGCACTCGCTACTATGTGCTG   MMP-28 
AGGCCTCGGGGGTAGTAG   
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Table 2.  
Summary of metalloproteinases whose gene expression levels differ significantly between 
disc nucleus cells (NP) and articular chondrocytes. 
 
Gene P Fold 
Higher expression in NP  
MMP-2 <0.05 1.76 
MMP-14 <0.01 1.78 
ADAMTS-1 <0.05 5.61 
ADAMTS-2 <0.05 3.47 
ADAMTS-17 <0.01 1.92 
TIMP-1 <0.01 2.94 
Lower expression in NP  
MMP-1 <0.001 55.6 
MMP-3 <0.001 3.34 
MMP-7 <0.01 2.46 
MMP-8 <0.001 2.67 
MMP-10 <0.01 2.66 
MMP-11 <0.05 1.64 
MMP-13 <0.05 2.79 
MMP-16 <0.001 8.68 
MMP-19 <0.001 2.9 
MMP-20 <0.01 2.36 
MMP-21 <0.01 1.95 
MMP-23 <0.05 3.14 
MMP-24 <0.01 2.49 
MMP-28 <0.01 2.28 
ADAMTS-4 <0.01 5.46 
ADAMTS-5 <0.001 8.23 
ADAMTS-6 <0.001 1.73 
ADAMTS-14 <0.01 2.34 
ADAMTS-18 <0.001 2.68 
ADAMTS-19 <0.01 1.87 
TIMP-3 <0.05 240.16 
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MMP 1 2 3 7 8 9 10 11 12 13 14 15 16 17 19 20 21 23 24 25 27 28 
N ! ! ! ! ! ! !  !  !  !  !  !  !  !  !  !  !  !  !  !  !  !  
C ! ! ! ! ! ! !  !  !  !  !  !  !  !  !  !  !  !  !  !  !  !  
 
                      
ADAMTS 1 2 4 5 6 7 8 9 10 12 13 14 15 16 17 18 19 20     
N ! ! ! ! ! ! !  !  !  !  !  !  !  !  !  !  !  !      
C ! ! ! ! ! ! !  !  !  !  !  !  !  !  !  !  !  !      
 
                      
TIMP 1 2 3 4            !  Not detected    
N ! ! ! !            !  Low expression   
C ! ! ! !            !  Medium expression  
                !  High expression   
Figure 1. Summary of Levels of MMP, ADAMTS and TIMP Gene Expression in Disc 
Nucleus Cells and Articular Chondrocytes Relative differential expression of the genes for 
matrix metalloproteinases (MMPs), ADAMTS, and tissue inhibitor of metalloproteinases 
(TIMPs) genes in nucleus cells (N) and in chondrocytes (C). Expression was classified 
according to the mean 2-CT of each gene (CT is the polymerase chain reaction cycle at which 
a positive signal is first measurable above background) and grouped into ranges. The 
gray-scale of the cell-shading with the expression range set at 1.0 x 10-2(high), 1.0 x 
10-6(normal), 1.0 x 10-8(low), and not detected (n.d.) arbitrary units. The typical results show 
mean results from quintuplicate of a single experiment. 
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Figure 2. Comparative expression of mRNA, relative to 18S ribosomal RNA, for MMP genes 
isolated from samples of bovine disc nucleus cells (N, ) and articular cartilage (C, ). 
Horizontal bars show mean results from quintuplicate of a single experiment.  Samples on or 
below solid line were not detectable (n.d.). * represents p<0.05, ** p<0.01 and *** p<0.001 
for mean differences between C and N.   
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Figure 3. Comparative expression of mRNA, relative to 18S ribosomal RNA, for ADAMTS 
genes isolated from samples of bovine disc nucleus cells (N, ) and articular cartilage (C, ). 
Horizontal bars show mean results from quintuplicate of a single experiment.  Samples on or 
below solid line were not detectable (n.d.). * represents p<0.05, ** p<0.01 and *** p<0.001  
 19 
 
 
Figure 4. Comparative expression of mRNA, relative to 18S ribosomal RNA, for TIMP genes 
isolated from samples of bovine disc nucleus cells (N, ) and articular cartilage (C, ). Horizontal 
bars show the mean expression. Samples on or below solid line were not detectable (n.d.). 
 * represents p<0.05 and ** p<0.01. 
 
